AGP Picks
View all

Market Forecast Reports: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Market Forecast Reports.

Press releases published on October 2, 2026

APP Investors Have Opportunity to Lead AppLovin Corporation Securities Fraud Lawsuit with SBS Law
FLNC Investors Have Opportunity to Lead Fluence Energy, Inc. Securities Fraud Lawsuit with SBS Law
ARDX Investors Have Opportunity to Lead Ardelyx, Inc. Securities Fraud Lawsuit with SBS Law
BETR Investors Have Opportunity to Lead Better Home & Finance Holding Company Securities Fraud Lawsuit with SBS Law
PLUS Mainnet Launches Layer-1 Blockchain with $945M Reserves
QFIN Investors Have Opportunity to Lead Qfin Holdings, Inc. Securities Fraud Lawsuit with SBS Law
Perspective Therapeutics Announces Acceptance of [212Pb]VMT01 Data for Presentation at SITC 2026
HONA Investors Have Opportunity to Lead Honeywell Aerospace Inc. Securities Fraud Lawsuit with SBS Law
These High-Voltage Stocks Are Suddenly Impossible to Ignore
Boris Vujčić: Resilience, integration and competitiveness: building the future of European banking
Electricity Price Change Notification

Electricity Price Change Notification

Industrial Water Action Workshop in partnership with Nike: Apply to Attend
TYGO Investors Have Opportunity to Lead Tigo Energy, Inc. Securities Fraud Lawsuit with SBS Law
Crypto News: Pepeto Announces Its Bridge Is Live as the XRP Price Prediction Targets $27
DEADLINE ALERT for FLNC, QFIN, DAVA, and AVXL : The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Gov. Evers, DATCP Announce Dairy Processor Grant Recipients, Next Application Period Open

Gov. Evers, DATCP Announce Dairy Processor Grant Recipients, Next Application Period Open

DEADLINE ALERT for TYGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Bronstein, Gewirtz & Grossman LLC Urges Innventure, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Biogen’s Litifilimab Demonstrates Rapid and Durable Efficacy in New 52-Week Phase 2 Data from Ongoing Phase 2/3 AMETHYST Study, Reinforcing Its Potential as a First-in-Class Therapy for Cutaneous Lupus Erythematosus
Minister Kajzer and German Foreign Minister Wadephul discuss strengthening the strategic partnership

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Market Forecast Reports

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.